JP2006515620A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515620A5
JP2006515620A5 JP2006500813A JP2006500813A JP2006515620A5 JP 2006515620 A5 JP2006515620 A5 JP 2006515620A5 JP 2006500813 A JP2006500813 A JP 2006500813A JP 2006500813 A JP2006500813 A JP 2006500813A JP 2006515620 A5 JP2006515620 A5 JP 2006515620A5
Authority
JP
Japan
Prior art keywords
insulin
use according
medicament
oral administration
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006500813A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006515620A (ja
JP5452843B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/000273 external-priority patent/WO2004062587A2/en
Publication of JP2006515620A publication Critical patent/JP2006515620A/ja
Publication of JP2006515620A5 publication Critical patent/JP2006515620A5/ja
Application granted granted Critical
Publication of JP5452843B2 publication Critical patent/JP5452843B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006500813A 2003-01-06 2004-01-06 夜間の経口インスリン治療 Expired - Fee Related JP5452843B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US43819503P 2003-01-06 2003-01-06
US43845103P 2003-01-06 2003-01-06
US60/438,195 2003-01-06
US60/438,451 2003-01-06
US47896703P 2003-06-16 2003-06-16
US60/478,967 2003-06-16
PCT/US2004/000273 WO2004062587A2 (en) 2003-01-06 2004-01-06 Night-time oral insulin therapy

Publications (3)

Publication Number Publication Date
JP2006515620A JP2006515620A (ja) 2006-06-01
JP2006515620A5 true JP2006515620A5 (https=) 2007-03-01
JP5452843B2 JP5452843B2 (ja) 2014-03-26

Family

ID=32719186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006500813A Expired - Fee Related JP5452843B2 (ja) 2003-01-06 2004-01-06 夜間の経口インスリン治療

Country Status (8)

Country Link
US (1) US7384914B2 (https=)
EP (1) EP1592438B1 (https=)
JP (1) JP5452843B2 (https=)
AU (1) AU2004204727B8 (https=)
CA (1) CA2511530C (https=)
ES (1) ES2465496T3 (https=)
NZ (1) NZ541058A (https=)
WO (1) WO2004062587A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1332711C (zh) 2002-02-20 2007-08-22 埃米球科技有限公司 施用glp-1分子的方法
WO2004080401A2 (en) * 2003-03-06 2004-09-23 Emisphere Technologies, Inc. Oral insulin therapies and protocol
US20050203001A1 (en) 2004-03-05 2005-09-15 Emisphere Technologies, Inc. Oral insulin therapies and protocol
US20060286129A1 (en) 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
NZ551196A (en) * 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents
AU2005244985B2 (en) 2004-05-19 2011-09-01 Emisphere Technologies, Inc. Acyclovir formulations
CN101014360A (zh) * 2004-08-03 2007-08-08 埃米斯菲尔技术公司 抗糖尿病口服胰岛素-双胍组合物
WO2006072070A2 (en) 2004-12-29 2006-07-06 Emisphere Technologies, Inc. Pharmaceutical formulations of gallium salts
WO2006076692A1 (en) 2005-01-12 2006-07-20 Emisphere Technologies, Inc. Compositions for buccal delivery of parathyroid hormone
JP2008542235A (ja) * 2005-05-25 2008-11-27 ノボ・ノルデイスク・エー/エス 安定化ポリペプチド製剤
US8097584B2 (en) * 2005-05-25 2012-01-17 Novo Nordisk A/S Stabilized formulations of insulin that comprise ethylenediamine
WO2007121318A2 (en) 2006-04-12 2007-10-25 Emisphere Technologies, Inc. Formulations for delivering insulin
US8771712B2 (en) 2006-05-09 2014-07-08 Emisphere Technologies, Inc. Topical administration of acyclovir
JP5475443B2 (ja) 2006-06-28 2014-04-16 エミスフェアー・テクノロジーズ・インク 硝酸ガリウム製剤
WO2008132731A2 (en) * 2007-04-26 2008-11-06 Oramed Pharmaceuticals, Inc Methods and compositions for rectal administration of insulin
IL188647A0 (en) * 2008-01-08 2008-11-03 Orina Gribova Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
RU2494755C2 (ru) 2008-08-18 2013-10-10 Интера Био Лтд. Способы и композиции для перорального введения белков
CA2767342C (en) 2009-07-09 2018-05-01 Oshadi Drug Administration Ltd. Matrix carrier compositions, methods and uses
EP2461803B1 (en) 2009-08-03 2018-10-17 Emisphere Technologies, Inc. Fast-acting naproxen composition with reduced gastrointestinal effects
US20240315972A1 (en) 2021-07-12 2024-09-26 Zidkiyahu Simenhaus Protein containing bio-active compositions comprising cellulose microparticle carriers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863896A (en) 1984-05-03 1989-09-05 Technology Unlimited, Inc. Diabetic control by combined insulin forms
RU2066551C1 (ru) 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
US5780243A (en) * 1996-06-28 1998-07-14 Thaco Research, Ltd. Methods for the quantitative analysis of organic compounds
SE520392C2 (sv) * 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US7227033B2 (en) * 2002-01-09 2007-06-05 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
JP2004521857A (ja) * 2000-06-29 2004-07-22 エミスフェアー・テクノロジーズ・インク 活性剤の送達のための化合物及び組成物
NZ524138A (en) * 2000-09-06 2004-12-24 Emisphere Tech Inc Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents
US20020147135A1 (en) * 2000-12-21 2002-10-10 Oliver Schnell Method and device for producing an adapted travel treatment plan for administering a medicine in the event of a long-haul journey
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6828297B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US20030198666A1 (en) * 2002-01-07 2003-10-23 Richat Abbas Oral insulin therapy
US7137951B2 (en) * 2002-10-23 2006-11-21 Joseph Pilarski Method of food and insulin dose management for a diabetic subject
NZ551196A (en) 2004-05-14 2010-08-27 Emisphere Tech Inc Compounds and compositions for delivering active agents

Similar Documents

Publication Publication Date Title
JP2006515620A5 (https=)
Langoth et al. Thiolated Chitosans: Design and In Vivo Evaluation of a Mucoadhesive Buccal Peptide Drug Delivery System: Langoth et al.
US10130684B2 (en) Oral dissolving films for insulin administration, for treating diabetes
US20160346288A1 (en) 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal
KR20070116946A (ko) 당뇨 치료에서의 혈중 포도당의 우수한 조절
WO2009048945A1 (en) Rapid mucosal gel or film insulin compositions
US20240238374A1 (en) Methods and compositions for inducing brown adipogenesis
JP7444786B2 (ja) 低用量の安定なグルカゴンを使用する肥満治療手術後の低血糖症の処置
JP2008509145A (ja) 抗糖尿病性経口インスリン−ビグアニドの組み合わせ
US20210379059A1 (en) Combination of substances for regenerative therapy in patients with type 1 diabetes mellitus
US20130096048A1 (en) Treatment of sepsis and septic shock using ghrelin and growth hormone
JPH07556B2 (ja) 間質性膀胱炎に対する治療用医薬組成物
RU2371195C2 (ru) Способ лечения вирусных инфекций
AU2018329496A1 (en) Sublingual epinephrine tablets
Pozzilli et al. A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8)
JP2012532852A (ja) 2型糖尿病における食後高血糖の経頬粘膜治療の方法、および当該治療に用いられる医薬組成物
JP2021506933A (ja) 1型糖尿病およびインスリン使用2型糖尿病における運動誘発性低血糖の処置
Nzerue et al. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure
CN101217960B (zh) 用于改善尿毒症的治疗药和处置方法
CN110169976A (zh) 含有腺苷a1受体激动剂的抗抑郁药物组合物及其应用
CN105663152A (zh) 三乙酰基-3-羟基苯基腺苷在制备改善胰岛素抵抗及相关疾病中的应用
CN1346278A (zh) 麻醉的调节
JP2006519881A5 (https=)
Kumbhar et al. Novel route of inhaled insulin for diabetes treatment
EP4631499A1 (en) Delayed timed release pharmaceutical composition, preparation method therefor, and use thereof